<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="63792">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01948037</url>
  </required_header>
  <id_info>
    <org_study_id>NanjingJH</org_study_id>
    <nct_id>NCT01948037</nct_id>
  </id_info>
  <brief_title>Effectiveness Study of Hydrotherapy Against Pain and Other Symptoms in Diabetes-induced LEAD</brief_title>
  <official_title>Hydrotherapy for the Treatment of Symptomatic Lower Extremity Arterial Disease in Diabetes Type 2 Patients:A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nanjing Jinling Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nanjing Jinling Hospital</source>
  <oversight_info>
    <authority>China: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to investigate whether the hydrotherapy are effective in against
       pain and other symptoms in diabetes-induced LEAD.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change from the intensity of numbness and cold feeling at 4 weeks. Change from the improvement of the pain index at 4 weeks.</measure>
    <time_frame>4 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from ankle-brachial index at 4 weeks</measure>
    <time_frame>4 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Change from flow velocity values at 4 weeks</measure>
    <time_frame>4 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Diabetes</condition>
  <condition>Lower Extremity Arterial Disease</condition>
  <arm_group>
    <arm_group_label>hydrotherapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>hot spring</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>30-minutes/per day;4weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>hydrotherapy</intervention_name>
    <description>30-minutes/per day,for 4weeks</description>
    <arm_group_label>hydrotherapy</arm_group_label>
    <arm_group_label>hot spring</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>hydrotherapy</intervention_name>
    <description>30-minutes/per day;4weeks</description>
    <arm_group_label>hydrotherapy</arm_group_label>
    <arm_group_label>hot spring</arm_group_label>
    <other_name>hot spring</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of Type 2 diabetes mellitus

          -  diagnosis of lower extremity arterial disease

        Exclusion Criteria:

          -  Severe heart disease

          -  can't hydrotherapy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>48 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Qiu Y bin</last_name>
    <role>Study Chair</role>
    <affiliation>Nanjing Jinling Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nanjing Jinling Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210002</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jia Wei, Master</last_name>
      <phone>86-025-80805491</phone>
      <email>1736429392@qq.com</email>
    </contact>
    <investigator>
      <last_name>Qiu Y Bin, Bachelor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>September 18, 2013</lastchanged_date>
  <firstreceived_date>September 13, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hydrotherapy</keyword>
  <keyword>randomized controlled trial</keyword>
  <keyword>lower extremity arterial disease</keyword>
  <keyword>diabetes</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
